cell therapeutics

Possible Bearish Dark Cloud Cover Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Thu, 04/26/2012 - 06:35
By Mallory Stone in Candlestick, CTIC, am dark cloud cover, cell therapeutics, nasdaq:ctic
CTIC

By Mallory Stone
mstone@fnno.com

Possible Bearish Dark Cloud Cover Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Wed, 04/25/2012 - 14:03
By Adrienne Chilton in Candlestick, CTIC, cell therapeutics, dark cloud cover, nasdaq:ctic
CTIC

By Adrienne Chilton
achilton@fnno.com

Possible Bearish Engulfing Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Thu, 01/26/2012 - 07:07
By Peter Chu in Candlestick, CTIC, bearish am engulfing candle, cell therapeutics, nasdaq:ctic
CTIC

By Peter Chu
pchu@fnno.com

Possible Bearish Harami Candle Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Mon, 01/09/2012 - 14:38
By Mallory Stone in Candlestick, CTIC, bearish harami, cell therapeutics, nasdaq:ctic
CTIC

By Mallory Stone
mstone@fnno.com

Possible Bearish Harami Candle Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Mon, 01/09/2012 - 07:12
By Mallory Stone in Candlestick, CTIC, bearish am harami, cell therapeutics, nasdaq:ctic
CTIC

By Mallory Stone
mstone@fnno.com

Possible Bullish Engulfing Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Fri, 01/06/2012 - 07:11
By Robert Cotter in Candlestick, CTIC, bullish am engulfing candle, cell therapeutics, nasdaq:ctic
CTIC

By Robert Cotter
rcotter@fnno.com

Possible Bullish Engulfing Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Thu, 01/05/2012 - 14:36
By Adrienne Chilton in Candlestick, CTIC, bullish engulfing candle, cell therapeutics, nasdaq:ctic
CTIC

By Adrienne Chilton
achilton@fnno.com

Possible Bearish Harami Candle Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Wed, 11/30/2011 - 14:41
By Peter Chu in Candlestick, CTIC, bearish harami, cell therapeutics, nasdaq:ctic
CTIC

By Peter Chu
pchu@fnno.com

Possible Bearish Harami Candle Pattern Detected for Cell Therapeutics (NASDAQ:CTIC)

Published on Wed, 11/30/2011 - 07:15
By Adrienne Chilton in Candlestick, CTIC, bearish am harami, cell therapeutics, nasdaq:ctic
CTIC

By Adrienne Chilton
achilton@fnno.com

Cell Therapeutics Posts Bigger Q4 Loss After Paying Share Di

Published on Wed, 02/16/2011 - 14:56
By Tim Tracy in General Interest, analysis, business, cell therapeutics, cti, earnings, eps, financial, market, news, stock, trading, Earnings Reports

CTIC stated that it paid out $14.4 million in deemed dividends on preferred stock, and that the payments were related to financing activities.

The company said the loss amounted to $34.1 million, compared with $27.4 million last year. Loss per share decreased to $0.04 from $0.05, due to the company's sale of additional stock over the last year.

Analysts, in a survey with Thomson Reuters, had expected a fourth-quarter loss of $0.02 per share.

analysis, business, cell therapeutics, cti, earnings, eps, financial, market, news, stock, trading

Cell Therapeutics (CTIC) reported a larger fourth quarter loss, which it attributed to an increase in dividends on preferred stock.

By Tim Tracy
ttracy@fnno.com

Latest News from FNNO

Analyst Rating In Review: Ducommun Sold ...

One week ago Ducommun (NYSE:DCO) was downgraded from Buy to Hold at BB&T Capital. The ...

Analyst Rating Flashback: Analog Devices...

Analog Devices was downgraded from Buy to Neutral by UBS one week ago. The shares clos ...

Janney Montgomery Made the Right Call, C...

Chiquita Brands International was downgraded from Buy to Neutral by Janney Montgomery o ...

CF Industries Gives Way to the Analysts:...

One week ago CF Industries (NYSE:CF) was downgraded from Hold to Sell at Dahlman Rose. ...

Parkway Properties Down 2.9% Since BMO C...

A week ago, BMO Capital upgraded Parkway Properties from Underperform to Market Perform ...

Analyst Rating In Review: Marvell Techno...

One week ago Marvell Technology (NASDAQ:MRVL) was downgraded from Buy to Neutral at UBS ...

Analyst Rating In Review: MercadoLibre S...

A week ago, Raymond James downgraded MercadoLibre from Outperform to Market Perform. T ...

Analyst Rating Flashback: Humana Down 3....

A week ago, Goldman Sachs downgraded Humana from Buy to Neutral. Humana stocks closed ...

Most Popular Video News